What is the treatment for hepatorenal syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Hepatorenal Syndrome

The first-line treatment for hepatorenal syndrome is terlipressin plus albumin, which has a response rate of 40-50% in patients with HRS Type 1. 1

Diagnostic Criteria

Before initiating treatment, confirm the diagnosis of hepatorenal syndrome:

  • Increased serum creatinine (>133 μmol/L or 1.5 mg/dL)
  • Exclusion of other causes of renal failure
  • Perform diagnostic paracentesis with SAAG calculation
  • Abdominal and renal ultrasound to confirm cirrhosis, assess portal hypertension, and rule out obstructive uropathy 1

Treatment Algorithm

First-Line Treatment: Terlipressin plus Albumin

  • Dosing regimen:
    • Terlipressin: Start at 1 mg IV every 4-6 hours
    • Increase to maximum 2 mg every 4-6 hours if serum creatinine does not decrease by at least 25% after 3 days
    • Albumin: 1 g/kg on day 1, followed by 20-40 g/day 1
  • Important limitation: Patients with serum creatinine >5 mg/dL are unlikely to experience benefit 2
  • Predictors of favorable response:
    • Serum bilirubin <10 mg/dL before treatment
    • Increase in mean arterial pressure >5 mm Hg at day 3 of treatment
    • Lower baseline serum creatinine (<5.0 mg/dL) 1

Alternative Treatments

  1. Norepinephrine plus albumin (in ICU setting) 1
  2. Midodrine + octreotide + albumin 1
    • Midodrine: Titrate up to 12.5 mg orally three times daily
    • Octreotide: 200 μg subcutaneously three times daily
    • Albumin: 10-20 g/day IV for up to 20 days
    • Note: This regimen can be administered outside the ICU and even at home 1

Monitoring and Complications

  • Monitor serum creatinine, mean arterial pressure, and cardiovascular status
  • Cardiovascular complications occur in approximately 12% of patients treated with terlipressin 1
  • Recurrence after withdrawal of terlipressin therapy is uncommon, and retreatment is generally effective 1

Prevention Strategies

  • Norfloxacin (400 mg/day) reduces the incidence of HRS in advanced cirrhosis 1
  • Pentoxifylline (400 mg three times daily) may prevent HRS development in severe alcoholic hepatitis 1
  • Treatment of spontaneous bacterial peritonitis with albumin plus antibiotics reduces the risk of HRS development 1

Definitive Treatment

  • Liver transplantation is the only curative treatment for HRS 1
  • Expedited referral for transplantation should be considered for all patients with cirrhosis, ascites, and HRS
  • Simultaneous liver-kidney transplantation should be considered for patients with significant kidney damage 1

Bridge Therapies

  • Continuous renal replacement therapy (RRT) may be used as a bridge to liver transplantation in non-responders to vasoconstrictors 1
  • Transjugular Intrahepatic Portosystemic Shunt (TIPS) may be considered in selected patients with partial response to medical therapy, but is contraindicated in severe liver failure or significant encephalopathy 1

Prognosis

Despite treatment, the prognosis for HRS patients remains poor, with a median survival of approximately 3 months for all HRS patients. Untreated Type 1 HRS has a median survival of approximately 1 month, emphasizing the importance of early diagnosis and treatment 1.

References

Guideline

Hepatorenal Syndrome Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.